Enlivex Announces Tokenization of Ordinary Shares via Ondo Global Markets

On April 8, 2026, Enlivex Ltd. (Nasdaq: ENLV) announced that Ondo Finance has launched ENLVon, a tokenized representation of Enlivex’s ordinary shares on the Ondo Global Markets platform. This initiative allows non-U.S. retail and institutional investors to gain direct economic exposure to Enlivex shares via digital infrastructure without requiring a traditional brokerage account. ENLVon tokens can be held in digital wallets and integrated into various financial applications, including lending and yield-generating strategies. Enlivex describes itself as a 'quality longevity company' that utilizes a dual strategy: advancing Allocetra™, a clinical-stage immunotherapy for inflammatory conditions like age-related osteoarthritis, and operating a prediction markets treasury strategy built on the Rain protocol. The company views this tokenization as a way to expand accessibility to digitally native investors. While the filing focuses on this financial infrastructure development, Enlivex continues its clinical development of Allocetra™, though no specific upcoming trial data readout dates were provided in this document.